Skip to main content
NewslettersWatchlist

Curaleaf Holdings Inc(CURA-T)
TSX

Today's Change
Real-Time Last Update
Day Low6.81
Day High7.05
Open:7.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Curaleaf Holdings: Top 10 Undervalued Growth Stocks on TSX (CURA)
Newswire.ca
Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply
AllPennyStocks.com
Cannabis Company Announces Expansion into the Czech Republic
Baystreet
Stocks in play: Curaleaf Holdings
AI-generated - The Globe and Mail
Curaleaf Holdings: Top 10 Undervalued Growth Stocks on TSX (CURA)
Newswire.ca
Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results
The Globe and Mail
Germany decriminalizes recreational cannabis, but falls short of initial plans to open market quickly
Newswire.ca
Curaleaf Celebrates New Phoenix Airport Dispensary
Newswire.ca
Curaleaf's Select Brand Expands Portfolio With Launch of Select Stiq
Newswire.ca
Curaleaf International Acquires Can4Med, Expanding Presence in Poland's Growing Medical Cannabis Market
AI-generated - The Globe and Mail
Curaleaf Holdings: Top 25 Undervalued Toronto Stock Exchange Stocks (CURA)
AI-generated - The Globe and Mail
Curaleaf Holdings: Stocks Overvalued by Analyst Consensus on TSX (CURA)
AI-generated - The Globe and Mail
Curaleaf Holdings: Top 10 Undervalued Growth Stocks on TSX (CURA)
Newswire.ca
Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix
Newswire.ca
Curaleaf Holdings Inc. Opens the Market

Profile

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.